Category: Include on Menu
-
Novocure Shares Slide After Phase 3 Glioblastoma Study Falls Short of Survival Goal
Novocure (NASDAQ:NVCR) shares dropped 10% after the company reported that its Phase 3 TRIDENT trial failed to achieve its primary objective of demonstrating a statistically significant improvement in overall survival for patients with newly diagnosed glioblastoma. The results disappointed investors who had been looking for evidence that earlier use of the company’s Tumor Treating Fields…
-
Oklo and Centrus Advance Ohio Nuclear Project With Fuel Supply Agreement (OKLO)
Oklo Inc. (NYSE:OKLO) and Centrus Energy Corp. (AMEX:LEU) have taken a significant step toward supporting next-generation nuclear energy deployment in Ohio after signing a Letter of Intent covering the supply of high-assay low-enriched uranium (HALEU) for Oklo’s planned Aurora reactors. The agreement strengthens the fuel supply chain for advanced nuclear technology while supporting broader efforts…
-
Enphase Energy Climbs After Barclays Upgrade and New Product Rollout (ENPH)
Enphase Energy Inc (NASDAQ:ENPH) shares surged 6.7% in premarket trading on Thursday after receiving an analyst upgrade from Barclays and announcing the start of production shipments for a new commercial microinverter designed for large-scale solar installations. The combination of a more constructive outlook from Wall Street and progress in the company’s product pipeline helped lift…
-
HIVE Digital Rallies on $220 Million AI Infrastructure Agreement and Swedish Data Center Acquisition
HIVE Digital Technologies Ltd. (NASDAQ:HIVE) shares surged 11.8% in premarket trading on Thursday after the company announced a major GPU cloud computing contract worth approximately $220 million and revealed plans to acquire a data center in Sweden. The announcements mark a significant expansion of HIVE’s high-performance computing business as demand for artificial intelligence infrastructure continues…
-
Accenture Slides After Revenue Miss and Reduced Full-Year Forecast (ACN)
Accenture (NYSE:ACN) shares fell sharply after the technology consulting giant reported fiscal third-quarter earnings that exceeded expectations but delivered weaker-than-anticipated revenue and bookings, while also trimming its full-year growth outlook. The stock dropped 11% to around 138 following the results, extending a difficult year for shareholders after the shares had already fallen roughly 40% in…
-
Kroger Delivers Revenue Beat While Reaffirming Full-Year Outlook (KR)
The Kroger Co. (NYSE:KR) reported first-quarter results that matched Wall Street’s earnings expectations and exceeded revenue forecasts, although the shares moved lower in premarket trading following the announcement. The grocery retailer posted adjusted earnings per share of $1.58, in line with analyst estimates, while revenue increased 2.2% year-over-year to $46.1 billion, ahead of the consensus…
-
Dollar Strengthens as Markets See Hawkish Signals in Fed Decision
The U.S. dollar advanced on Thursday after investors interpreted the Federal Reserve’s latest policy meeting and subsequent commentary as reinforcing the case for higher interest rates, prompting traders to increase expectations for further monetary tightening. The greenback gained ground against major currencies as markets reacted to what many viewed as a more hawkish-than-expected outcome from…
-
Is Tech Heading for a Correction? Intel and Marvell Technology Are Expensive – Could Lahontan Gold Be a Rotation Winner?
Intel: Operational Pressure Forces Smart Capital Model As an integrated chip manufacturer, Intel serves the PC and server market with its own processors and also acts as a contract manufacturer for external chip designers. To relieve pressure on the balance sheet amid high operating losses in the foundry business, the group, under the leadership of Lip-Bu…
-
Globex Mining has trounced the TSX since 2016: Why to stay bullish
While mining is an essential industry, supplying us with the basic materials that make up the products and services at the heart of our everyday lives, from lithium in electric vehicle batteries, to gold in our jewelry, to copper cables enabling the Internet, to nickel for the steel support structures in our homes, investing in…
-
Oral Wegovy Captures One-Third of Prescriptions as Adoption Continues to Accelerate
Novo Nordisk (NYSE:NVO) is seeing strong uptake of its oral Wegovy treatment, with the tablet formulation accounting for roughly one-third of all Wegovy prescriptions by May, according to a Bank of America report published on Thursday. The data highlights the rapid adoption of the oral version since its market debut earlier this year and underscores…